Arama Sonu&ccedil;lar&#305; - Daralt&#305;lm&#305;&#351;: T&#305;p -- Avrupa Birli&#287;i SirsiDynix Enterprise http://katalog.istanbul.edu.tr/client/tr_TR/default_tr/default_tr/qf$003dSUBJECT$002509Konu$002bBa$0025C5$00259Fl$0025C4$0025B1$0025C4$00259F$0025C4$0025B1$002509T$0025C4$0025B1p$002b--$002bAvrupa$002bBirli$0025C4$00259Fi$002509T$0025C4$0025B1p$002b--$002bAvrupa$002bBirli$0025C4$00259Fi$0026lm$003dIUHFK$0026ps$003d300$0026isd$003dtrue?dt=list 2020-02-25T00:54:26Z EU research fighting the three major deadly diseases : HIV/AIDS, Malaria and tuberculosis 1st edition EU projects 2007-2010 ent://SD_ILS/0/SD_ILS:675862 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Comission.<br/>Format:&#160;Kitaplar<br/> Programme of Community Action in the Field of Public Health Projects Funded Under the Call for Proposals 2006 ent://SD_ILS/0/SD_ILS:631589 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Executive Health, Public.<br/>Format:&#160;Kitaplar<br/> EUR 23132 - From Fundamental Genomics to Systems Biology: Understanding the book of life ent://SD_ILS/0/SD_ILS:636108 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Annual Report 2007 : The State of the Drugs Problem in Europe ent://SD_ILS/0/SD_ILS:631590 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Centre Monitoring, European.<br/>Format:&#160;Kitaplar<br/> Health research with developing countries ent://SD_ILS/0/SD_ILS:674607 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Research Commission, European.<br/>Format:&#160;Kitaplar<br/> Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs ent://SD_ILS/0/SD_ILS:591141 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Centre Monitoring, European.<br/>Format:&#160;Kitaplar<br/> Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs ent://SD_ILS/0/SD_ILS:591142 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Centre Monitoring, European.<br/>Format:&#160;Kitaplar<br/> Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs ent://SD_ILS/0/SD_ILS:611437 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Centre Monitoring, European.<br/>Format:&#160;Kitaplar<br/> Drugs and security : public opinion regarding security and victimisation in the European Union : contact with drug-related problems ent://SD_ILS/0/SD_ILS:611475 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Commission, European.<br/>Format:&#160;Kitaplar<br/> Report on the risk assessment of ketamine in the framework of the joint action in new synthetic drugs ent://SD_ILS/0/SD_ILS:675219 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities.<br/>Format:&#160;Kitaplar<br/> Evaluation and monitoring of screening programmes ent://SD_ILS/0/SD_ILS:673873 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> General report of activities 2000 ent://SD_ILS/0/SD_ILS:674819 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Centre Monitoring, European.<br/>Format:&#160;Kitaplar<br/> European guidelines for quality assurance in mammography screening ent://SD_ILS/0/SD_ILS:674944 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commisson.<br/>Format:&#160;Kitaplar<br/> Guidlines for the evaluation of outreach work : a manuel for outreach practitioners ent://SD_ILS/0/SD_ILS:675053 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Centre Monitoring, European.<br/>Format:&#160;Kitaplar<br/> European network on HIV/AIDS and hepatitis prevention in prisons ent://SD_ILS/0/SD_ILS:675212 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Injecting drug see, risk behaviour and qualitative research in the time of AIDS ent://SD_ILS/0/SD_ILS:675391 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Rhodes, Tim .<br/>Format:&#160;Kitaplar<br/> First Conference on International Harmanisation of Veterinary Medicinal Products, 16-18 November 1999-Brussels, Belgium ent://SD_ILS/0/SD_ILS:673875 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> General report on the activities 1999 ent://SD_ILS/0/SD_ILS:674644 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction.<br/>Format:&#160;Kitaplar<br/> Pharmaceuticals in the European Union ent://SD_ILS/0/SD_ILS:674825 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Commission, European.<br/>Format:&#160;Kitaplar<br/> Work programme for the European Agency for the Evaluation of Medicinal Products : 2000-2001 : adopted by the Management Board on 22 February 2000. ent://SD_ILS/0/SD_ILS:675202 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Agency for the Evaluation of Medicinal Products.<br/>Format:&#160;Kitaplar<br/> 2000 Annual report on the state of the drugs problem in the European Union ent://SD_ILS/0/SD_ILS:675209 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drugs Addiction.<br/>Format:&#160;Kitaplar<br/> Guidelines for the risk assessment of new synthetic drugs ent://SD_ILS/0/SD_ILS:673656 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction.<br/>Format:&#160;Kitaplar<br/> Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs ent://SD_ILS/0/SD_ILS:673659 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction.<br/>Format:&#160;Kitaplar<br/> Biomedical and health reearch programme 1994-1998 : summaries of research projects supported under Biomed 2 ent://SD_ILS/0/SD_ILS:673669 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commision.<br/>Format:&#160;Kitaplar<br/> General report of activities 1998 ent://SD_ILS/0/SD_ILS:673681 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction .<br/>Format:&#160;Kitaplar<br/> Outreach work among drug users in Europe : concepts, practice, and terminology ent://SD_ILS/0/SD_ILS:673983 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction .<br/>Format:&#160;Kitaplar<br/> Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs ent://SD_ILS/0/SD_ILS:673986 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction.<br/>Format:&#160;Kitaplar<br/> The rulse governing medicinal products in the European Union Guidelines : veterinary medicinal products ent://SD_ILS/0/SD_ILS:674019 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Guidelines : veterinary medicinal products: general, efficacy, environmental risk assessment ent://SD_ILS/0/SD_ILS:675401 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> European Monitoring Centre for Drugs and Drug Addiction : General report of activities 1997 ent://SD_ILS/0/SD_ILS:673639 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction.<br/>Format:&#160;Kitaplar<br/> Annual report on the state of the drugs problem in the European Union ent://SD_ILS/0/SD_ILS:673878 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction .<br/>Format:&#160;Kitaplar<br/> Report on osteoporosis in the European Community : Action for prevention ent://SD_ILS/0/SD_ILS:674328 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Pharmaceutical legislation : medicinal products for human use ent://SD_ILS/0/SD_ILS:675245 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Pharmaceutical legislation : veterinary medicinal products ent://SD_ILS/0/SD_ILS:675247 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Notice to applicants: veterinary medinical products: presentation and content of the dossier ent://SD_ILS/0/SD_ILS:675250 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Guidelines : medicinal product for human use : efficacy ent://SD_ILS/0/SD_ILS:675396 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Guidelines : medicinal product for human use : safety, environment and information ent://SD_ILS/0/SD_ILS:675399 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Guidelines : medicinal product for human use : quality and biotechnology ent://SD_ILS/0/SD_ILS:675402 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Notice to applicants: medinical products for human use: presentation and content of the dossier ent://SD_ILS/0/SD_ILS:675406 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Notice to applicants: medinical products for human use: procedures for marketing authorisation ent://SD_ILS/0/SD_ILS:675408 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Criteria for acceptability of radiological (including radiotherapy) and nuclear medicine installations ent://SD_ILS/0/SD_ILS:673661 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> The European Union in action against drugs ent://SD_ILS/0/SD_ILS:673666 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Work programme : 1997-98 ent://SD_ILS/0/SD_ILS:673670 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Agency for the Evaluation of Medicinal Products.<br/>Format:&#160;Kitaplar<br/> Group of advisers to the European Commission : on the ethical immplicatios of biotechnology ent://SD_ILS/0/SD_ILS:673679 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Die europaische union im kampf gegen drogen ent://SD_ILS/0/SD_ILS:674035 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Europaische Gemeinschaften .<br/>Format:&#160;Kitaplar<br/> The European Union in action against drugs ent://SD_ILS/0/SD_ILS:674037 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Annual report on the state of the drugs problem in the European Union ent://SD_ILS/0/SD_ILS:674043 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Annual report on the state of the drugs problem in the European Union ent://SD_ILS/0/SD_ILS:674044 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Pharmaceutical legislation : medicinal products for human and veterinary use : good manufacturing practices ent://SD_ILS/0/SD_ILS:675347 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> The state of health in the European Community ent://SD_ILS/0/SD_ILS:673672 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> Group of advisers to the European Commission on the ethical implications of biotechnology ent://SD_ILS/0/SD_ILS:673674 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> The European Agency for the Evaluation of Medicinal Products : directory 1996 ent://SD_ILS/0/SD_ILS:673676 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Agency for the Evaluation of Medicinal Products.<br/>Format:&#160;Kitaplar<br/> Committee for proprietary medicinal products : european public assessment report ent://SD_ILS/0/SD_ILS:673677 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Agency for the Evaluation of Medicinal Products.<br/>Format:&#160;Kitaplar<br/> Urban districts and drug scenes:: A comparative study on nuisance caused by 'open' drug scenes in major European cities ent://SD_ILS/0/SD_ILS:673682 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Union ent://SD_ILS/0/SD_ILS:674004 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> European guidelines for quality assurance in mammography screening : Europe against cancer ent://SD_ILS/0/SD_ILS:674045 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Evaluation of the European Drug Prevention Week, 1994 : technical report, IPS, Paris, May 1995 ent://SD_ILS/0/SD_ILS:674316 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Union ent://SD_ILS/0/SD_ILS:674329 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Pharmaceutical sector : coordinated instruments : position on 31.12.1994 ent://SD_ILS/0/SD_ILS:674307 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Union : The rules governing medicinal products for human use in the European Union ent://SD_ILS/0/SD_ILS:674325 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Union : Guuidelines for the testing of veterinary medicinal products ent://SD_ILS/0/SD_ILS:673651 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission .<br/>Format:&#160;Kitaplar<br/> Who&rsquo;s who : value relay centres ent://SD_ILS/0/SD_ILS:674611 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Commission.<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Community : The rules governing veterinary medicinal producrs in the Euopean Community ent://SD_ILS/0/SD_ILS:673646 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission .<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Community : Notice to applicants for marketing authorization for veterinary medicinal products in the European Community ent://SD_ILS/0/SD_ILS:673880 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission .<br/>Format:&#160;Kitaplar<br/> Health related data and epidemiology in the European community ent://SD_ILS/0/SD_ILS:674948 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Monitoring Centre for Drugs and Drug Addiction .<br/>Format:&#160;Kitaplar<br/> Inventory of EC (legal) texts on drugs ent://SD_ILS/0/SD_ILS:675546 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;Commission of the European Communities.<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal rpoducts in the European Community : Addendum no 2 : Guidelines on the quality, safety and efficacy of medicinal products for human use ent://SD_ILS/0/SD_ILS:673642 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission.<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Community : Good manufcacturing practice for medicinal products ent://SD_ILS/0/SD_ILS:673876 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission .<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Community : Establisment by the European Community of maximum residue limits (MRLs) for residues of veterinary medicinal products in foodstuffs of animal origin ent://SD_ILS/0/SD_ILS:673647 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission.<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Community : The rules governing medicinal products for human use in the European Community ent://SD_ILS/0/SD_ILS:673653 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission .<br/>Format:&#160;Kitaplar<br/> The rules governing medicinal products in the European Community : Guidelines on the quality, safety and efficacy of medicinal products for human use ent://SD_ILS/0/SD_ILS:673636 2020-02-25T00:54:26Z 2020-02-25T00:54:26Z by&#160;European Communities - Commission .<br/>Format:&#160;Kitaplar<br/>